Editorial Commentary
Fourth-generation epidermal growth factor receptor-tyrosine kinases inhibitors: hope and challenges
Translational Cancer Research
2024;
13
(8)
:3929-3934
.
(31 August 2024)
Trimodality therapy in the modern era for management of bladder cancer
Translational Cancer Research
2024;
13
(8)
:3935-3939
.
(31 August 2024)
Treatment of appendiceal neuroendocrine tumour: a controversial treatment for a misunderstood neoplasm in a mysterious organ
Translational Cancer Research
2024;
13
(8)
:3940-3943
.
(31 August 2024)
Original Article
The expression of programmed cell death ligand 1 (PD-L1) involves in the clinicopathologic characteristics and prognostic implications of testicular germ cell tumor (TGCT): a systematic review and meta-analysis
Translational Cancer Research
2024;
13
(8)
:3944-3959
.
(31 August 2024)
Bioinformatics analysis-based mining of potential markers for inflammatory bowel disease and their immune relevance
Translational Cancer Research
2024;
13
(8)
:3960-3973
.
(31 August 2024)
Unveiling the role of RARs in stomach adenocarcinoma: clinical implications and prognostic biomarkers
Translational Cancer Research
2024;
13
(8)
:3974-3995
.
(31 August 2024)
Upregulation of CKS2 in immunosuppressive cells is associated with metastasis and poor prognosis in prostate cancer: a single-cell RNA-sequencing analysis
Translational Cancer Research
2024;
13
(8)
:3996-4009
.
(31 August 2024)
Development and validation of a diagnostic and prognostic model for bone metastasis of intrahepatic cholangiocarcinoma: a population-based analysis
Translational Cancer Research
2024;
13
(8)
:4010-4027
.
(31 August 2024)
AIBP promotes cell proliferation and migration through the ERK1/2-MAPK signaling pathway in hepatocellular carcinoma
Translational Cancer Research
2024;
13
(8)
:4028-4041
.
(31 August 2024)
The potential role of breast MRI in evaluation of triple-negative breast cancer and fibroadenoma of less than 3 cm
Translational Cancer Research
2024;
13
(8)
:4042-4051
.
(31 August 2024)
The peripheral CD4+ T cells predict efficacy in non-small cell lung cancer (NSCLC) patients with the anti-PD-1 treatment
Translational Cancer Research
2024;
13
(8)
:4052-4061
.
(31 August 2024)
Integrative analysis of the role of the DPH gene family in hepatocellular carcinoma and expression validation
Translational Cancer Research
2024;
13
(8)
:4062-4084
.
(31 August 2024)
An ensemble learning model for predicting cancer-specific survival of muscle-invasive bladder cancer patients undergoing bladder preservation therapy
Translational Cancer Research
2024;
13
(8)
:4085-4095
.
(31 August 2024)
Comprehensive pan-cancer analysis reveals CDC6 as a potential immunomodulatory agent and promising therapeutic target in pancreatic cancer
Translational Cancer Research
2024;
13
(8)
:4096-4112
.
(31 August 2024)
Long non-coding RNA MIR4435-2HG promotes pancreatic cancer progression by regulating ABHD17C through sponging miR-128-3p
Translational Cancer Research
2024;
13
(8)
:4113-4130
.
(31 August 2024)
A nomogram for overall survival of second primary cancers following upper-tract urothelial carcinoma: a SEER population-based study
Translational Cancer Research
2024;
13
(8)
:4131-4145
.
(31 August 2024)
Efficacy and safety of immune checkpoint inhibitors plus platinum-etoposide vs. platinum-etoposide in the first-line treatment of extensive-stage small cell lung cancer: a systematic review and a meta-analysis
Translational Cancer Research
2024;
13
(8)
:4146-4158
.
(31 August 2024)
TSPAN1 overexpression as an indicator of poor prognosis in estrogen receptor-positive breast cancer
Translational Cancer Research
2024;
13
(8)
:4159-4171
.
(31 August 2024)
Hsa_circ_0002360 promotes the progression of lung adenocarcinoma by activating miR-762 and regulating PODXL expression
Translational Cancer Research
2024;
13
(8)
:4172-4186
.
(31 August 2024)
Predictive model of gene expression regulating invasion and migration of M2 macrophages in breast cancer: clinical prognosis and therapeutic implications
Translational Cancer Research
2024;
13
(8)
:4187-4204
.
(31 August 2024)
The role of chromatin modulator DPY30 in glucose metabolism of colorectal cancer cells
Translational Cancer Research
2024;
13
(8)
:4205-4218
.
(31 August 2024)
Effectiveness of Paxlovid in the treatment of the SARS-CoV-2 Omicron variant infection in children with hematologic malignancies: a retrospective cohort study
Translational Cancer Research
2024;
13
(8)
:4219-4230
.
(31 August 2024)
The expression of tumor necrosis factor receptor 2 is correlated with the prognosis of cancer: a systematic review and meta-analysis
Translational Cancer Research
2024;
13
(8)
:4231-4241
.
(31 August 2024)
Bioinformatics analysis of SH2D4A in glioblastoma multiforme to evaluate immune features and predict prognosis
Translational Cancer Research
2024;
13
(8)
:4242-4256
.
(31 August 2024)
Identifying epithelial-mesenchymal transition-related genes as prognostic biomarkers and therapeutic targets of hepatocellular carcinoma by integrated analysis of single-cell and bulk-RNA sequencing data
Translational Cancer Research
2024;
13
(8)
:4257-4277
.
(31 August 2024)
Analysis of the ideal cutoff age as a predictor of differentiated thyroid cancer using the Surveillance, Epidemiology, and End Results database
Translational Cancer Research
2024;
13
(8)
:4278-4289
.
(31 August 2024)
Low-dose apatinib optimizes the vascular normalization and enhances the antitumor effect of PD-1 inhibitor in gastric cancer
Translational Cancer Research
2024;
13
(8)
:4290-4300
.
(31 August 2024)
Diagnostic and prognostic role of microRNA-525 in different cancers: a systematic review and meta-analysis
Translational Cancer Research
2024;
13
(8)
:4301-4314
.
(31 August 2024)
Exploring the therapeutic potential of simvastatin in pancreatic neuroendocrine neoplasms: insights into cell cycle regulation and apoptosis
Translational Cancer Research
2024;
13
(8)
:4315-4323
.
(31 August 2024)
A novel tumor-derived exosomal gene signature predicts prognosis in patients with pancreatic cancer
Translational Cancer Research
2024;
13
(8)
:4324-4340
.
(31 August 2024)
Effect of Agkistrodon acutus venom (AAVC-I) on apoptosis through modulation of the Keap1/Nrf2 pathway in HSC-3 oral squamous cell carcinoma cells
Translational Cancer Research
2024;
13
(8)
:4341-4353
.
(31 August 2024)
Identification of genes predicting chemoresistance and short survival in ovarian cancer
Translational Cancer Research
2024;
13
(8)
:4354-4371
.
(31 August 2024)
Integrated analysis of the lncRNA-miRNA-mRNA ceRNA network in nasopharyngeal carcinoma
Translational Cancer Research
2024;
13
(8)
:4372-4388
.
(31 August 2024)
Characterization and validation of a prognostic model for the N6-methyladenosine-associated ferroptosis gene in colon adenocarcinoma
Translational Cancer Research
2024;
13
(8)
:4389-4407
.
(31 August 2024)
Special tissue microbiota such as Cyanobacteria are associated with the immune microenvironment of lung adenocarcinoma
Translational Cancer Research
2024;
13
(8)
:4408-4419
.
(31 August 2024)
Development of an immunogenic cell death-related lncRNAs signature for prognostic risk assessment in gastric cancer
Translational Cancer Research
2024;
13
(8)
:4420-4440
.
(31 August 2024)
PA-MSHA exerts potent activity against cetuximab-resistant colorectal cancer through the miR-7-5p/Akt3/Wnt-β-catenin pathway
Translational Cancer Research
2024;
13
(8)
:4441-4458
.
(31 August 2024)
GGT5 as a promising prognostic biomarker and its effects on tumor cell progression in gastric cancer
Translational Cancer Research
2024;
13
(8)
:4459-4473
.
(31 August 2024)
The diagnostic performance of the Mindray system in detecting CA125 and HE4 for patients with ovarian cancer
Translational Cancer Research
2024;
13
(8)
:4474-4484
.
(31 August 2024)
Bioinformatic prediction of miR-320a as a potential negative regulator of CDGSH iron-sulfur domain 2 (CISD2), involved in lung adenocarcinoma bone metastasis via MYC activation, and associated with tumor immune infiltration
Translational Cancer Research
2024;
13
(8)
:4485-4499
.
(31 August 2024)
Feasibility and safety of transarterial chemoembolization in patients with liver cancer via the distal radial approach: a single-center retrospective cohort study
Translational Cancer Research
2024;
13
(8)
:4500-4506
.
(31 August 2024)
Erratum
Erratum to erratum to miR-3614-3p suppresses cell aggressiveness of human breast cancer by targeting AKT3 and HDAC1 expression
Translational Cancer Research
2024;
13
(8)
:4507-4509
.
(31 August 2024)
